Hepatitis E vaccine shows promising 10-year efficacy in the Chinese population : vimarsana.com

1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable concentrations of antibodies persisted at the 8.5-year mark in Qindong. Evidence Rating Level: 1 (Excellent) Study Rundown: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide. Currently, two recombinant HEV vaccines exist; however, little is known

Related Keywords

Qindong , Gansu , China , Dongtai , Jiangsu , Chinese , , Rating Level , Between Aug , Dongtai County , Gastroenterology , Hepatitis , Hepatitis E , Hepatitise Vaccine , Hepatitise Virus Hev , Liver , Chronic Disease , Infectious Disease ,